These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 33884099)
41. Recent Advances in Studies on the Therapeutic Potential of Dietary Carotenoids in Neurodegenerative Diseases. Cho KS; Shin M; Kim S; Lee SB Oxid Med Cell Longev; 2018; 2018():4120458. PubMed ID: 29849893 [TBL] [Abstract][Full Text] [Related]
42. Natural Products in Neurodegenerative Diseases: A Great Promise but an Ethical Challenge. Di Paolo M; Papi L; Gori F; Turillazzi E Int J Mol Sci; 2019 Oct; 20(20):. PubMed ID: 31635296 [TBL] [Abstract][Full Text] [Related]
43. Effect of natural exogenous antioxidants on aging and on neurodegenerative diseases. Guerra-Araiza C; Álvarez-Mejía AL; Sánchez-Torres S; Farfan-García E; Mondragón-Lozano R; Pinto-Almazán R; Salgado-Ceballos H Free Radic Res; 2013 Jul; 47(6-7):451-62. PubMed ID: 23594291 [TBL] [Abstract][Full Text] [Related]
44. Determination of Parameters of Oxidative Stress in vitro Models of Neurodegenerative Diseases-A Review. Feitosa CM; da Silva Oliveira GL; do Nascimento Cavalcante A; Morais Chaves SK; Rai M Curr Clin Pharmacol; 2018; 13(2):100-109. PubMed ID: 29493463 [TBL] [Abstract][Full Text] [Related]
45. Chelating and antioxidant properties of l-Dopa containing tetrapeptide for the treatment of neurodegenerative diseases. Cacciatore I; Marinelli L; Di Stefano A; Di Marco V; Orlando G; Gabriele M; Gatta DMP; Ferrone A; Franceschelli S; Speranza L; Patruno A Neuropeptides; 2018 Oct; 71():11-20. PubMed ID: 29937392 [TBL] [Abstract][Full Text] [Related]
46. Oxidative Stress and Antioxidants in Neurological Diseases: Is There Still Hope? Carvalho AN; Firuzi O; Gama MJ; Horssen JV; Saso L Curr Drug Targets; 2017 Mar; 18(6):705-718. PubMed ID: 27033198 [TBL] [Abstract][Full Text] [Related]
47. Nerolidol and its Pharmacological Application in Treating Neurodegenerative Diseases: A Review. De Carvalho RBF; De Almeida AAC; Campelo NB; Lellis DROD; Nunes LCC Recent Pat Biotechnol; 2018; 12(3):158-168. PubMed ID: 29210667 [TBL] [Abstract][Full Text] [Related]
48. Nanotechnology and antioxidant therapy: an emerging approach for neurodegenerative diseases. Fernandes C; Oliveira C; Benfeito S; Soares P; Garrido J; Borges F Curr Med Chem; 2014; 21(38):4311-27. PubMed ID: 25245378 [TBL] [Abstract][Full Text] [Related]
49. Therapeutic Potential of Natural Antioxidants. Ramana KV; Reddy ABM; Majeti NVRK; Singhal SS Oxid Med Cell Longev; 2018; 2018():9471051. PubMed ID: 30186551 [No Abstract] [Full Text] [Related]
50. Role of oxidative stress and antioxidants in neurodegenerative diseases. Rao AV; Balachandran B Nutr Neurosci; 2002 Oct; 5(5):291-309. PubMed ID: 12385592 [TBL] [Abstract][Full Text] [Related]
51. Natural Products in Therapeutic Management of Multineurodegenerative Disorders by Targeting Autophagy. Shaikh S; Ahmad K; Ahmad SS; Lee EJ; Lim JH; Beg MMA; Verma AK; Choi I Oxid Med Cell Longev; 2021; 2021():6347792. PubMed ID: 34557265 [TBL] [Abstract][Full Text] [Related]
52. Ingredients for functional drinks in neurodegenerative diseases: a review. Zafrilla P; Morillas JM; Rubio-Perez JM; Cantos Villar E Nat Prod Commun; 2009 May; 4(5):719-40. PubMed ID: 19445320 [TBL] [Abstract][Full Text] [Related]
53. Antioxidant Effect of Flavonoids Present in Euterpe oleracea Martius and Neurodegenerative Diseases: A Literature Review. de Oliveira NKS; Almeida MRS; Pontes FMM; Barcelos MP; de Paula da Silva CHT; Rosa JMC; Cruz RAS; da Silva Hage-Melim LI Cent Nerv Syst Agents Med Chem; 2019; 19(2):75-99. PubMed ID: 31057125 [TBL] [Abstract][Full Text] [Related]
54. An overview of the pathophysiology of neurodegenerative disorders. Willner C Altern Ther Health Med; 2004; 10(4):26-34; quiz 35, 96. PubMed ID: 15285272 [No Abstract] [Full Text] [Related]
55. Recent Updates on the Dynamic Association Between Oxidative Stress and Neurodegenerative Disorders. Khan TA; Hassan I; Ahmad A; Perveen A; Aman S; Quddusi S; Alhazza IM; Ashraf GM; Aliev G CNS Neurol Disord Drug Targets; 2016; 15(3):310-20. PubMed ID: 26831262 [TBL] [Abstract][Full Text] [Related]
56. Neurodegenerative drug discovery: building on the past, looking to the future. Bolognesi ML Future Med Chem; 2017 May; 9(8):707-709. PubMed ID: 28504913 [No Abstract] [Full Text] [Related]
57. Role of Melatonin in Aluminum-Related Neurodegenerative Disorders: a Review. Esparza JL; Gómez M; Domingo JL Biol Trace Elem Res; 2019 Mar; 188(1):60-67. PubMed ID: 29732485 [TBL] [Abstract][Full Text] [Related]
58. Mitochondrial dysfunction in psychiatric and neurological diseases: cause(s), consequence(s), and implications of antioxidant therapy. Kasote DM; Hegde MV; Katyare SS Biofactors; 2013; 39(4):392-406. PubMed ID: 23460132 [TBL] [Abstract][Full Text] [Related]
59. Efficacy of Sulforaphane in Neurodegenerative Diseases. Schepici G; Bramanti P; Mazzon E Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33207780 [TBL] [Abstract][Full Text] [Related]